Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Results from a Phase 1 Study of ACTR707 in Combination with Rituximab in Patients with Relapsed or Refractory CD20+ B Cell Lymphoma.
Journal: Transplantation and cellular therapy
Published: May 22, 2023
Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study.
Journal: The Lancet. Haematology
Published: June 01, 2018
Nonalloreactive T cells prevent donor lymphocyte infusion-induced graft-versus-host disease by controlling microbial stimuli.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: November 09, 2012
Showing 1-3 of 3
Last Updated: 09/26/2026